Literature DB >> 6295171

Ocular histopathologic studies of neonatal and childhood adrenoleukodystrophy.

S M Cohen, W R Green, Z C de la Cruz, F R Brown, H W Moser, M W Luckenbach, D J Dove, I H Maumenee.   

Abstract

Histopathologic studies of the eyes of one patient (a boy who died at 14 years of age) with childhood adrenoleukodystrophy and two patients (girls who died at 24 and 31 months of age) with neonatal adrenoleukodystrophy showed the accumulation of the characteristic bileaflet inclusions in optic nerve macrophages, retinal neurons, and macrophages and loss of ganglion cell and nerve fiber layer. Additionally, in the two cases of neonatal adrenoleukodystrophy, changes resembling early retinitis pigmentosa were found, with accumulation of characteristic inclusions in the retinal pigment epithelium and pigment-laden macrophages. One of the patients with neonatal adrenoleukodystrophy also had an anterior subcapsular cataract and cystoid macular edema.

Entities:  

Mesh:

Year:  1983        PMID: 6295171     DOI: 10.1016/0002-9394(83)90336-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

1.  A pathological study of a peripheral nerve in a case of neonatal adrenoleukodystrophy.

Authors:  T Mito; K Takada; S Akaboshi; S Takashima; K Takeshita; Y Origuchi
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  Retinal Ganglion Cell Loss in X-linked Adrenoleukodystrophy with an ABCD1 Mutation (Gly266Arg).

Authors:  Yasuhiro Ohkuma; Takaaki Hayashi; Syouyou Yoshimine; Hiroshi Tsuneoka; Yoko Terao; Masaharu Akiyama; Hiroyuki Ida; Toya Ohashi; Akihisa Okumura; Nobuyuki Ebihara; Akira Murakami; Nobuyuki Shimozawa
Journal:  Neuroophthalmology       Date:  2014-10-09

Review 3.  Ophthalmic manifestations of inherited neurodegenerative disorders.

Authors:  Hannah M Kersten; Richard H Roxburgh; Helen V Danesh-Meyer
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

4.  The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder.

Authors:  Shandi Hiebler; Tomohiro Masuda; Joseph G Hacia; Ann B Moser; Phyllis L Faust; Anita Liu; Nivedita Chowdhury; Ning Huang; Amanda Lauer; Jean Bennett; Paul A Watkins; Donald J Zack; Nancy E Braverman; Gerald V Raymond; Steven J Steinberg
Journal:  Mol Genet Metab       Date:  2014-01-23       Impact factor: 4.797

5.  RhoA/ROCK signaling regulates TGFβ-induced epithelial-mesenchymal transition of lens epithelial cells through MRTF-A.

Authors:  Anna Korol; Aftab Taiyab; Judith A West-Mays
Journal:  Mol Med       Date:  2016-09-29       Impact factor: 6.354

Review 6.  Optic atrophies in metabolic disorders.

Authors:  Marjan Huizing; Brian P Brooks; Yair Anikster
Journal:  Mol Genet Metab       Date:  2005-09-27       Impact factor: 4.797

Review 7.  Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review.

Authors:  Mousumi Bose; Christine Yergeau; Yasmin D'Souza; David D Cuthbertson; Melisa J Lopez; Alyssa K Smolen; Nancy E Braverman
Journal:  Cells       Date:  2022-06-10       Impact factor: 7.666

8.  Leopard spot retinal pigmentation in infancy indicating a peroxisomal disorder.

Authors:  C J Lyons; G Castano; A Q McCormick; D Applegarth
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

9.  Peroxisome biogenesis disorders.

Authors:  Catherine Argyriou; Maria Daniela D'Agostino; Nancy Braverman
Journal:  Transl Sci Rare Dis       Date:  2016-11-07

10.  High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot.

Authors:  Susanna Croci; Miriam Lucia Carriero; Katia Capitani; Sergio Daga; Francesco Donati; Elisa Frullanti; Vittoria Lamacchia; Rossella Tita; Annarita Giliberti; Floriana Valentino; Elisa Benetti; Annalisa Ciabattini; Simone Furini; Caterina Lo Rizzo; Anna Maria Pinto; Silvestro Giovanni Conticello; Alessandra Renieri; Ilaria Meloni
Journal:  Eur J Hum Genet       Date:  2020-04-24       Impact factor: 4.246

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.